Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.
Mark P HamiltonTakeshi SugioTroy NoordenbosShuyu ShiPhilip L BulterysChih Long LiuXiaoman KangMari N OlsenZinaida GoodSaurabh DahiyaMatthew J FrankBita SahafCrystal L MackallDita GratzingerMaximilian DiehnAsh A AlizadehDavid B MiklosPublished in: The New England journal of medicine (2024)
Our results highlight the rarity of second tumors and provide a framework for defining clonal relationships and viral vector monitoring. (Funded by the National Cancer Institute and others.).